1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 18th March 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Cyclophosphamide

Discussion in 'Drug and supplement treatments' started by Jaybee00, Dec 23, 2018.

  1. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    13,273
    Location:
    London, UK
    Matching a nausea-inducing placebo would not be convincing in my view.
    The only way to address this sort of problem is to do a dose response study. With varying doses everyone will get some nausea but because nausea is very unpredictable in severity nobody will know what dose they are having. If the drug works it should show a dose dependent response. More people should improve on a bigger dose up to a certain limit.

    The real problem with cyclophosphamide is that there is no longer any convincing theoretical basis for using it and it is such an unpleasant drug in terms of unwanted effects (especially bladder cancer) that I personally would advise strongly against any further testing.
     
  2. BurnA

    BurnA Senior Member (Voting Rights)

    Messages:
    410
    Do you believe ritux failure means cyclo failure or is there another reason you say that there is no theoretical basis.

    The theoretical basis for ritux was built out of anecdotal reports of delayed responses from patients post cancer treatment.
    Does this not fit with cyclo?
     
  3. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    13,273
    Location:
    London, UK
    The serendipitous improvement of lymphoma patients with ME on immunoablative therapies suggested that some cases might be autoimmune or perhaps hyperimmune/auto inflammatory as in psoriasis. The only reasonably safe and effective treatments for such conditions are either anti-TNF drugs (which do not work in ME) or rituximab (neither). (There are some other classes of biologic drug but if these two do not work at all there is little reason to think the others will.) Cyclophosphamide has in the past been used for crises in life-threatening autoimmune disease but is largely obsolete because of toxicity. We never knew why it worked if it did. The doses that had a clear effect produced high rate os bladder cancer oil the long term.

    Put differently, to justify drug usage I think we need a plausible theoretical goal like killing B or T cells or blocking TNF. 'Immunosupression' is not enough.

    If anything cyclophosphamide probably works best as a B cell killing agent, but it is not as good as rituximab. Moreover, we now have no real reason to think B cells or antibodies are involved in ME. The autoantibody studies are essentially negative.
     
  4. Marky

    Marky Senior Member (Voting Rights)

    Messages:
    588
    Location:
    Norway
    Is there any data on what immune cells cyclo typically kills percentage wise?
     
    ukxmrv likes this.
  5. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    13,273
    Location:
    London, UK
    Lots but it depends on the dose. It kills a lot of B cells at low dose but they may well be the ones due to die anyway. It kills some T cells but stimulates others. It is much too complicated to get any handle on really. Maybe the only thing we really know is that lethal doses, followed by stem cell rescue, can reprogram the immune system enough to allow grafts and get rid of autoimmune disease for about 5 years, but probably not longer.
     
  6. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    1,858
    Sarah94 likes this.
  7. Milo

    Milo Senior Member (Voting Rights)

    Messages:
    2,107
    I was wondering whether our Norwegian friends have more information as of when the Cyclophosphamide paper will publish, if at all? It’s taking a very long time...
     
    rainy, mango and Kalliope like this.
  8. Kalliope

    Kalliope Senior Member (Voting Rights)

    Messages:
    6,237
    Location:
    Norway
    As far as I know the study has been submitted and it's down to the journal now when it gets published.
     
    Nellie, Trish, Snow Leopard and 5 others like this.
  9. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    1,858
    I’m wondering if perhaps the manuscript was rejected. I’m guessing it was submitted in August 2019. That’s about 7 months—long enough to do the review, make revisions and have it published.
     
  10. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    1,858
    Last edited by a moderator: Jul 7, 2020
  11. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    1,858
    Cyclophosphamide is used as a treatment for many diseases.
     
  12. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    1,858

Share This Page